Opioid Taper Study Finds Added Therapy Does Not Boost Success
Published: 08/5/2026

Anyone facing a prescribed opioid taper wants to know two things. Will the dose reduction hold, and how rough will it feel. A randomized controlled trial published July 7 in the Annals of Internal Medicine answers the first question in a way that may surprise patients and clinicians alike.
Adding structured behavioral support to a patient-centered opioid taper did not improve taper success at 12 months. The finding does not mean behavioral support has no role. The safety numbers point in a different direction and, therefore, is where the clinical value sits.
What the Trial Measured
Beth D. Darnall, PhD, of the Stanford University School of Medicine and colleagues compared three opioid tapering and pain control strategies across 11 US sites.
The study enlisted adults with pain lasting at least six months, receiving a morphine equivalent daily dose of 10 or higher for at least three months. Importantly, participants did not have moderate or severe opioid use disorder.
The three arms consisted of taper only, taper plus cognitive behavioral therapy for chronic pain, and taper plus a chronic pain self-management program, with 191, 203 and 168 patients, respectively.
As such, taper success rates came in at 50.9% for taper only, 48.6% for taper plus pain-focused CBT, and 44.5% for taper plus the self-management program. Neither added program outperformed the taper alone.
Why Medical Detox and Supervised Tapering Are Not the Same Thing
This distinction matters enough to state plainly. For instance, the trial studied prescribed opioid tapering in people with chronic pain who did not have moderate or severe opioid use disorder.
It did not study medical detox for opioid use disorder. Therefore, readers shouldn’t interpret the results as guidance for someone dependent on heroin, fentanyl, or misused prescription opioids.
Medical detox is a supervised withdrawal management process for people with substance dependence, usually delivered with medication to control withdrawal symptoms and stabilize the patient.
A prescribed taper reduces a therapeutic dose gradually under a treating clinician. As such, the two overlap in physiology but differ in setting, goal, and standard of care.
Where the Behavioral Programs Did Show a Difference
The adverse event data had the clearest practical read. The taper-only group had the highest rate of study-related adverse event risk, including opioid withdrawal symptoms, at 66 percent.
That compares with 54 percent in the taper plus pain-CBT group and 64 percent in the taper plus self-management group. Put simply, the added behavioral support did not make the taper more likely to succeed, but the group with no added support had the roughest ride.
“For patients, I think the data are reassuring that if opioids are tapered the right way, meaning a patient-centered approach, people can significantly reduce their opioid doses without having increased pain long term,” Darnall said in a statement.
Understanding Medication-Assisted Treatment
For opioid use disorder, which this trial did not examine, medication-assisted treatment remains the evidence-based standard. Buprenorphine and methadone are opioid agonist medications that reduce withdrawal symptoms and cravings by acting on the same receptors as other opioids without producing the same intensity of effect.
Naltrexone is an opioid antagonist used after withdrawal is complete to block opioid effects. In addition, these medications are used both during withdrawal management and as ongoing maintenance treatment, and continuation after detox is associated with substantially better outcomes than detox alone.
Finding Medical Detox Programs
For those taking prescribed opioids and want to reduce your dose, the first conversation belongs with your prescribing clinician, not with an internet protocol. Accordingly, ask whether a patient-centered taper is appropriate, over what timeline, and available support if withdrawal symptoms become difficult.
If the situation is opioid dependence rather than a prescribed taper, look for detox programs that offer medication-assisted treatment and a defined handoff into continuing care.
Detox.com’s directory lets you search medically supervised detox centers by location and confirm which medications and levels of care each one provides. In addition, call 800-996-6135 to get contact with a treatment specialist today.

